Articles

Galenvs Sciences Wins Innovative Solutions Canada Phase 1 Award

Galenvs Sciences Wins Innovative Solutions Canada Phase 1 Award

Galenvs Sciences is pleased to announce that the company was awarded Phase 1 funding to answer one of the challenges proposed by Innovative Solutions Canada: Magnetic reagents for detection of COVID-19 and other RNA based molecular diagnostic kits challenge....